Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer
Recruiting now · Not applicable
Conditions studied: NMIBC
In brief
Residual tumors after transurethral resection of bladder tumors (TURBT) range from 17-70%, and floating tumor cells from traditional segmental resection may lead to recurrence if they re-implant in the bladder wall. Immediate systemic chemotherapy post-surgery aims to eliminate microlesions promptly and minimize recurrence risk, yet its safety and efficacy require further exploration. This prospective, single-arm study delves into evaluating the efficacy and safety of immediate postoperative systemic chemotherapy in patients with suspected high-risk non-muscle-invasive bladder cancer.
Key facts
- Study ID
- NCT06889623
- Run by
- Changhai Hospital
- People needed
- 72
- Starts
- 2024-06-01
- Expected to finish
- 2028-06-01
- Last updated by the study team
- 2025-03-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with a history and cystoscopy results indicating high-risk NMIBC:
- High-grade T1
- Any recurrent high-grade Ta
- High-grade Ta \& Tumor diameter greater than 3 cm or multifocal
- Any CIS
- Any BCG failure in patients with high-grade disease
- Any variant histology
- Any LVI
- Any high-grade prostatic urethral involvement
- Patients in generally good condition with a follow-up period of 2 years
You may not qualify if…
- Bladder cancer other than UC
- MIBC or benign diseases
- Incomplete tumor resection
- Active infection
- Concurrent upper urinary tract or prostatic urethral UC
- Previous systemic chemotherapy, immunotherapy, or radiotherapy
- Leukopenia/thrombocytopenia
- Serum creatinine greater than twice the normal level
- Uncontrollable urinary tract infection
Where it is running
- Shanghai Changhai Hospital — Shanghai, Shanghai Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.